Flora M. Haaijer‐Ruskamp

6.6k total citations
150 papers, 4.5k citations indexed

About

Flora M. Haaijer‐Ruskamp is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Flora M. Haaijer‐Ruskamp has authored 150 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Geriatrics and Gerontology, 48 papers in Economics and Econometrics and 31 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Flora M. Haaijer‐Ruskamp's work include Pharmaceutical Practices and Patient Outcomes (50 papers), Health Systems, Economic Evaluations, Quality of Life (40 papers) and Blood Pressure and Hypertension Studies (19 papers). Flora M. Haaijer‐Ruskamp is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (50 papers), Health Systems, Economic Evaluations, Quality of Life (40 papers) and Blood Pressure and Hypertension Studies (19 papers). Flora M. Haaijer‐Ruskamp collaborates with scholars based in Netherlands, United Kingdom and Sweden. Flora M. Haaijer‐Ruskamp's co-authors include Petra Denig, Peter G. M. Mol, Roy E. Stewart, Jan Schuling, Dick de Zeeuw, Larissa Grigoryan, Jaco Voorham, Cecilia Stålsby Lundborg, Bauke M. de Jong and Pieter A. de Graeff and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes Care.

In The Last Decade

Flora M. Haaijer‐Ruskamp

148 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Flora M. Haaijer‐Ruskamp Netherlands 36 1.4k 1.2k 965 753 645 150 4.5k
Asrul Akmal Shafie Malaysia 36 826 0.6× 1.3k 1.1× 707 0.7× 380 0.5× 420 0.7× 250 4.4k
Nadine Shehab United States 27 1.5k 1.1× 603 0.5× 442 0.5× 473 0.6× 986 1.5× 42 5.1k
Daniel S. Budnitz United States 33 2.1k 1.5× 733 0.6× 506 0.5× 515 0.7× 946 1.5× 70 6.7k
Michael A. Steinman United States 48 2.3k 1.7× 2.0k 1.7× 1.6k 1.6× 690 0.9× 1.1k 1.7× 214 8.3k
Daniel C. Malone United States 42 2.2k 1.6× 1.2k 1.0× 886 0.9× 267 0.4× 1.0k 1.6× 298 8.0k
Peter J. Kaboli United States 39 2.0k 1.5× 1.2k 1.1× 1.8k 1.8× 273 0.4× 1.0k 1.6× 169 6.2k
A. Russell Localio United States 34 744 0.5× 640 0.5× 1.4k 1.5× 526 0.7× 773 1.2× 77 7.3k
Shalom I. Benrimoj Australia 36 2.7k 1.9× 883 0.8× 2.0k 2.0× 373 0.5× 310 0.5× 184 4.8k
Björn Wettermark Sweden 41 863 0.6× 1.8k 1.5× 637 0.7× 274 0.4× 1.6k 2.5× 214 7.1k
Colin Bradley Ireland 38 880 0.6× 698 0.6× 2.1k 2.2× 466 0.6× 188 0.3× 159 5.2k

Countries citing papers authored by Flora M. Haaijer‐Ruskamp

Since Specialization
Citations

This map shows the geographic impact of Flora M. Haaijer‐Ruskamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flora M. Haaijer‐Ruskamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flora M. Haaijer‐Ruskamp more than expected).

Fields of papers citing papers by Flora M. Haaijer‐Ruskamp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flora M. Haaijer‐Ruskamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flora M. Haaijer‐Ruskamp. The network helps show where Flora M. Haaijer‐Ruskamp may publish in the future.

Co-authorship network of co-authors of Flora M. Haaijer‐Ruskamp

This figure shows the co-authorship network connecting the top 25 collaborators of Flora M. Haaijer‐Ruskamp. A scholar is included among the top collaborators of Flora M. Haaijer‐Ruskamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flora M. Haaijer‐Ruskamp. Flora M. Haaijer‐Ruskamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Vo, Dang-Khoa, et al.. (2013). The effect of a clinical pharmacist-led training programme on intravenous medication errors: a controlled before and after study. BMJ Quality & Safety. 23(4). 319–324. 41 indexed citations
3.
Denig, Petra, et al.. (2012). A pilot qualitative study to explore stakeholder opinions regarding prescribing quality indicators. BMC Health Services Research. 12(1). 191–191. 7 indexed citations
4.
Haaijer‐Ruskamp, Flora M., et al.. (2011). WHICH ASPECTS OF NEW GLUCOSE LOWERING DRUGS DO DIFFERENT STAKEHOLDERS VALUE? A QUALITATIVE STUDY. Pharmacoepidemiology and Drug Safety. 34(10). 896–896. 1 indexed citations
5.
Doormaal, Jasperien E. van, et al.. (2010). Comparison of methods for identifying patients at risk of medication-related harm. BMJ Quality & Safety. 19(6). e26–e26. 16 indexed citations
6.
Haaijer‐Ruskamp, Flora M., et al.. (2009). Safety Issues of HIV Drugs, Regulatory Consequences. Drug Safety. 32(10). 936–936. 1 indexed citations
7.
Braspenning, Jozé, Petra Denig, W.J.C. de Grauw, et al.. (2008). Prescribing quality indicators of type 2 diabetes mellitus ambulatory care. BMJ Quality & Safety. 17(5). 318–323. 28 indexed citations
8.
Dobre, Daniela, Dirk J. van Veldhuisen, Mike J.L. de Jongste, & Flora M. Haaijer‐Ruskamp. (2007). Prescription of Beta-Blockers in Patients with Advanced Heart Failure and Preserved Left Ventricular Ejection Fraction. Clinical Implications and Survival. European Journal of Heart Failure. 9(9). 962–963. 3 indexed citations
9.
Dobre, Daniela, Dirk J. van Veldhuisen, Mike J.L. DeJongste, et al.. (2006). Prescription of Beta-Blockers in Patients with Advanced Heart Failure and Preserved Left Ventricular Ejection Fraction. Clinical Implications and survival. European Journal of Heart Failure. 9(3). 280–286. 54 indexed citations
10.
Čižman, Milan, et al.. (2005). Self-medication with antibiotics in Slovenian general population. SHILAP Revista de lepidopterología. 4 indexed citations
11.
Denig, Petra, et al.. (2005). Perceived barriers for treatment of chronic heart failure in general practice; are they affecting performance?. BMC Family Practice. 6(1). 19–19. 20 indexed citations
12.
Sturm, Heidrun, et al.. (2005). The Relevance of Comorbidities for Heart Failure Treatment in Primary Care: A European Survey. European Journal of Heart Failure. 8(1). 31–37. 25 indexed citations
13.
Jaarsma, Tiny, Flora M. Haaijer‐Ruskamp, Heidrun Sturm, & Dirk J. van Veldhuisen. (2005). Management of Heart Failure in the Netherlands. European Journal of Heart Failure. 7(3). 371–375. 24 indexed citations
14.
Denig, Petra, et al.. (2004). Trends in antihypertensive drug prescribing and influence of comorbidities from 1996 to 2000. British Journal of Clinical Pharmacology. 58(1). 106–106. 1 indexed citations
15.
Dukes, M. N. G., et al.. (2003). Drugs and money; prices, affordibility and cost containment. University of Groningen research database (University of Groningen / Centre for Information Technology). 22 indexed citations
16.
Denig, Petra, et al.. (2002). Specialists' expectations regarding joint treatment guidelines for primary and secondary care. International Journal for Quality in Health Care. 14(6). 509–518. 18 indexed citations
17.
Lagerløv, Per, Catharina C. M. Schuiling‐Veninga, Eva Hummers, et al.. (2000). Asthma management in five European countries: doctors′ knowledge, attitudes and prescribing behaviour. European Respiratory Journal. 15(1). 25–25. 63 indexed citations
18.
Schuiling‐Veninga, Catharina C. M., Rolf Wahlström, Petra Denig, et al.. (1999). Evaluating an Educational Intervention to Improve the Treatment of Asthma in Four European Countries. American Journal of Respiratory and Critical Care Medicine. 160(4). 1254–1262. 74 indexed citations
19.
Haaijer‐Ruskamp, Flora M.. (1997). Rational drug use in Europe - Challenges for the 21(st) century - Report from the 1st Meeting of EURO DURG, the European Drug Utilization Research Group (editorial). European Journal of Clinical Pharmacology. 52(3). 1 indexed citations
20.
Berg, Lolkje T.W. de Jong‐van den, et al.. (1994). Journalists and their sources of ideas and information on medicines. Social Science & Medicine. 38(4). 637–643. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Asrul Akmal Shafie Breakdown of academic impact, for papers by Nadine Shehab Breakdown of academic impact, for papers by Daniel S. Budnitz Breakdown of academic impact, for papers by Michael A. Steinman Breakdown of academic impact, for papers by Daniel C. Malone Breakdown of academic impact, for papers by Peter J. Kaboli Breakdown of academic impact, for papers by A. Russell Localio Breakdown of academic impact, for papers by Shalom I. Benrimoj Breakdown of academic impact, for papers by Björn Wettermark Breakdown of academic impact, for papers by Colin Bradley
Rankless by CCL
2026